The startup operates a preclinical research platform that provides scientific expertise and strategic guidance to expedite drug development in oncology, immunology, metabolic, and CNS diseases. By offering a range of preclinical services and operational implementation, the company helps biotech and pharma clients navigate the complexities of drug development and achieve their business objectives.
Funding
$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Biotech and pharmaceutical companies often face challenges in efficiently managing and executing preclinical and clinical drug development, leading to delays and increased costs. Navigating the complexities of lead optimization, IND-enabling studies, and clinical trials requires specialized expertise and resources that may not be readily available in-house.
Solution
Radyus Research offers a fully integrated R&D platform designed to accelerate drug development from lead optimization through clinical proof-of-concept. By functioning as an extension of a client's R&D team, Radyus provides scientific expertise, strategic guidance, and operational execution across preclinical, clinical, manufacturing, and regulatory stages. The company streamlines processes and manages programs from start to finish, offering a cost-effective approach to achieving key milestones and attracting investors. Radyus's integrated model aims to reduce the time and resources required to advance drug candidates to IND and beyond.
Target Audience
Radyus Research primarily serves biotech companies, academic startups, and venture capital firms involved in drug development, particularly those in lead optimization and candidate selection stages.
Features
- Integrated R&D project planning and execution, covering preclinical and clinical stages
- Scientific expertise in indication selection, validation assays, and molecular design
- Support for candidate selection, including efficacy and safety studies, target product profile development, and regulatory strategy
- IND-enabling studies, GLP animal studies, GMP manufacturing, and quality assurance
- Clinical study design, CRO/CDMO audit, clinical operations, and bioanalysis
- Program management to oversee preclinical, clinical, manufacturing, and regulatory milestones